Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-09-27

FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's supplemental application for four amphetamine salt products (dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amphetamine Aspartate
  • Amphetamine sulfate (amphetamine sulfate)
  • Dextroamphetamine Saccharate
  • Dextroamphetamine sulfate (dextroamphetamine sulfate)

Snippet

SUPPL AP for DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE (DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE)